Stay updated with breaking news from Has No Impact. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Presentation highlights results from 13- and 39-week studies of eneboparatide in non-human primates demonstrating no evidence of deleterious impact on bone quantity or quality as measured by multiple bone
LYON, France and CAMBRIDGE, Mass., May 05, 2023 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced
Investegate announcements from NuCana plc, Technical Board of Appeal of the European Patent Office Issues Oral Ruling that NuCana’s ‘190 Patent is Not Valid
Nutrition significantly impacts IBD, but there’s a lot of misinformation out there. Rachel Dyckman, a dietitian with ulcerative colitis, debunks 5 of the most common myths surrounding nutrition and IBD.